For further characterization of the anti-PF4/heparin immune response in MPN, we performed immunoglobulin isotype testing in PV and ET to delineate the proportion of anti-PF4/heparin IgG with an established role in platelet activation via FcγRIIA [31]. Here, PF4 is linked to myeloproliferative neoplasm.